Arterial hypertension (AH) is a multifactorial clinical condition characterized by
sustained elevation of blood pressure (BP) levels ≥ 140 and/or 90 mm Hg. It
is often associated with metabolic disorders, functional and/or structural changes
in target organs, being worsened by the presence of other risk factors (RF), such as
dyslipidemia, abdominal obesity, glucose intolerance and diabetes mellitus
(DM).[1,2] It is independently associated with events such as
sudden death, stroke, acute myocardial infarction (AMI), heart failure (HF),
peripheral arterial disease (PAD) and fatal and non-fatal chronic kidney disease
(CKD).[1-4]
Medical and social impact of arterial hypertension
North American data from 2015 revealed the presence of AH in 69% of patients on
their first episode of AMI, in 77% of those with stroke, in 75% of those with HF
and in 60% of those with PAD.[5]
Arterial hypertension accounts for 45% of the cardiac deaths and for 51% of the
deaths due to stroke.[6]
Arterial hypertension and cardiovascular disease in Brazil
In Brazil, AH affects 32.5% (36 million) of the adults, over 60% of the elderly,
contributing direct or indirectly to 50% of the deaths due to cardiovascular
disease (CVD).[7] Along with DM,
its complications (cardiac, renal and stroke) have high impact on loss of work
productivity and on family income, estimated as US$ 4.18 billion from 2006 to
2015.[8]In 2013 there were 1,138,670 deaths, 339,672 of which (29.8%) due to CVD, the
major cause of death in Brazil (Figure
1).
Figure 1
Mortality rate in Brazil due to cardiovascular diseases (CVD) and
distribution according to cause in 2013. IHD: ischemic heart
disease; CbVD: cerebrovascular disease; HD: hypertensive disease;
CHF: congestive heart failure.
Mortality rate in Brazil due to cardiovascular diseases (CVD) and
distribution according to cause in 2013. IHD: ischemic heart
disease; CbVD: cerebrovascular disease; HD: hypertensive disease;
CHF: congestive heart failure.The mortality rates have decreased over the years, except for the hypertensive
diseases (HD), which increased from 2002 to 2009, showing a reduction trend
since 2010. The HD rates in that period ranged from 39/100,000 inhabitants
(2000) to 42/100,000 inhabitants. Ischemic heart diseases (IHD) dropped from
120.4/100,000 inhabitants (2000) to 92/100,000 inhabitants (2013),
cerebrovascular diseases (CbVD), from 137.7/100,000 inhabitants (2000) to
89/100,000 inhabitants (2013), and congestive HF (CHF), from 47.7/100,000
inhabitants (2000) to 24.3/100,000 inhabitants (2013)[9] (Figure
2).
Figure 2
Mortality rate in Brazil due to CVD from 2000 to 2013. Source:
Information System on Mortality. Health Surveillance Secretariat,
Brazilian Ministry of Health.
Mortality rate in Brazil due to CVD from 2000 to 2013. Source:
Information System on Mortality. Health Surveillance Secretariat,
Brazilian Ministry of Health.In addition, CVD account for the high frequency of hospitalizations, with high
socioeconomic costs. Data from the Hospital Information System of the Brazilian
Unified Public Health System point to a significant reduction in the
hospitalization trend due to AH, from 98.1/100,000 inhabitants (2000) to
44.2/100,000 inhabitants (2013).Historical hospitalization rates due to CVD by region are shown in Figure 3, with a reduction for HD and
stability or reduction trend for stroke, despite the increase in
hospitalizations due to IHD.
Figure 3
Hospitalization rate in Brazil per 100,000 inhabitants, per
geopolitical region, from 2010 to 2012.
Hospitalization rate in Brazil per 100,000 inhabitants, per
geopolitical region, from 2010 to 2012.
Prevalence of arterial hypertension
The prevalence of HA in Brazil varies according to the population studied and the
assessment method (Table 1).
Table 1
Prevalence of AH according to different approaches
Source
BP
n
General (%)
Men
Women
Picon et al.[10]*
Measured
17,085
28.7 (26.2-31.4)
27.3 (22.5-32.8)
27.7 (23.7-32.0)
Scala et al.[7]
Measured
21.9-46.6
-
-
VIGITEL, 2014**
Self-reported via telephone
40,853
25.0
PNS, 2013**
Self-reported
62,986
21.4
18.1
21.0
PNS, 2014**
Measured
59,402
22.3
25.3
19.5
BP: blood pressure.
Meta-analysis; studies from the 2000 decade.
Note: Self-declared hypertensives under treatment were not considered
hypertensive in the VIGITEL and PNS surveys.
Prevalence of AH according to different approachesBP: blood pressure.Meta-analysis; studies from the 2000 decade.Note: Self-declared hypertensives under treatment were not considered
hypertensive in the VIGITEL and PNS surveys.In the meta-analysis by Picon et al., the 40 cross-sectional and cohort studies
included showed a reduction trend in AH prevalence in the last three decades,
from 36.1% to 31.0%.[10] A study
with 15,103 government employees from six Brazilian capitals has reported a
35.8% AH prevalence, with predominance of men (40.1% vs 32.2%).[11]Data from VIGITEL (2006 to 2014) indicate that the self-reported AH prevalence
among individuals aged 18 years and over, living in the capitals, ranged from
23% to 25%, respectively, with no difference in the period assessed, not even
regarding sex. The self-reported AH prevalence varied among adults according to
age groups as follows: 18 - 29 years, 2.8%; 30 - 59 years, 20.6%; 60 - 64 years,
44.4%; 65 - 74 years, 52.7%; and ≥ 75 years, 55%. The Southeastern region
showed the highest self-reported AH prevalence (23.3%), followed by the Southern
(22.9%) and West-Central (21.2%) regions. The Northeastern and Northern regions
had the lowest rates, 19.4% and 14.5%, respectively.[12]In 2014, the Brazilian National Health Survey (PNS) measured the BP of selected
dwellers from drawn residences, using calibrated digital semi-automated devices.
Three BP measurements were taken at two-minute intervals, considering the mean
of the last two measurements, inserted in smartphone. The
overall prevalence of BP ≥140/90 mm Hg was 22.3%, with predominance among
men (25.3% vs 19.5%), ranging from 26.7% in Rio de Janeiro to
13.2% in Amazonas, with predominance in the urban area as compared to the rural
one (21.7% vs 19.8%).
Knowledge, treatment and control
A review[7] has shown a wide
variation of BP knowledge (22% to 77%), treatment (11.4% to 77.5%) and control
(10.1% to 35.5%) rates, depending on the population studied (Table 2).
Table 2
Blood pressure knowledge, treatment and control in 14 Brazilian
population-based studies published from 1995 to 2009.[7]
Author/year per geopolitical region
Place
Number of individuals
Knowledge
Treatment
Control
Southern
Fuchs et al. 1995
Porto Alegre (RS)
1,091
42.3
11.4
35.5
Gus et al. 2004
Rio Grande Sul
1,063
50.8
40.5
10.4
Oliveira e Nogueira, 2003
Cianorte (PR)
411
63.2
29.9
20.9
Trindade, 1998
Passo Fundo (RS)
206
82.2
53.3
20
Pereira et al. 2007
Tubarão (SC)
707
55.6
50.0
10.1
Southeastern
Freitas et al. 2001
Catanduva (SP)
688
77
61.8
27.6
Souza et al. 2003
Campos dos Goytacazes (RJ)
1,029
29.9
77.5
35.2
Barreto et al. 2001
Bambuí (MG)
2,314
76.6
62.9
27
Castro et al. 2007
Formiga (MG)
285
85.3
67.3
14.7
Mill et al. 2004
Vitória (ES)
1,656
27.0
West-Central
Jardim et al. 2007
Goiânia (GO)
1,739
64.3
43.4
12.9
Cassanelli, 2005
Cuiabá (MT)
1,699
68.3
68.5
16.6
Rosário et al. 2009
Nobres (MT)
1,003
73.5
61.9
24.2
Souza et al. 2007
Campo Grande (MS)
892
69.1
57.3
-
Blood pressure knowledge, treatment and control in 14 Brazilian
population-based studies published from 1995 to 2009.[7]
Prehypertension
Prehypertension (PH) is characterized by systolic BP (SBP) between 121 and 139
and/or diastolic BP (DBP) between 81 and 89 mm Hg.[13] The world prevalence of PH has ranged from 21%
to 37,7% in population-based studies, except for Iran (52.1%) (Figure 4).[14]
Figure 4
Prevalence of prehypertension (PH).
Prevalence of prehypertension (PH).Prehypertension associates with a higher risk of developing AH[15,16] and cardiac abnormalities.[17] Approximately one third of the cardiovascular
(CV) events attributed to BP elevation occur in individuals with PH.[18] Meta-analyses of the incidence
of CVD, IHD and stroke in prehypertensive individuals have shown a higher risk
among those with BP levels between 130 and 139 or 85 and 89 mm Hg than among
those with BP levels between 120 and 129 or 80 and 84 mm Hg (Figure 5).[14]
Figure 5
Meta-analysis of the risk of the incidence of cardiovascular disease
(CVD) in individuals with prehypertension (PH).
Meta-analysis of the risk of the incidence of cardiovascular disease
(CVD) in individuals with prehypertension (PH).The clinical implication of that epidemiological evidence is that the BP of
prehypertensive individuals should be monitored closely, because a significant
proportion of them will develop AH and its complications.[2]
Risk factors for arterial hypertension
Age
There is a direct and linear association between aging and AH prevalence
related to the increase: i) in life expectancy of the Brazilian population,
currently 74.9 years; ii) in the elderly population ≥ 60 years in the
past decade (2000 to 2010), from 6.7% to 10.8%.[19] A meta-analysis of studies performed in
Brazil including 13,978 elderly has shown a 68% AH prevalence.[20]
Sex and ethnicity
The 2013 Brazilian National Health Survey (PNS) showed a self-reported AH
prevalence statistically different between sexes, being higher among women
(24.2%) and black individuals (24.2%) as compared to mixed-heritage adults
(20.0%), but not white individuals (22.1%). The
Corações do Brasil Study has reported the
following distribution: native population, 11.1%; yellow population, 10%;
mixed heritage/mulatto, 26.3%; white, 29.4% and black, 34.8%.[21] The ELSA-Brazil Study has
shown the following prevalences: white, 30.3%; mixed heritage, 38.2%; and
black, 49.3%.[11]
Overweight and obesity
In Brazil, the 2014 VIGITEL data revealed, between 2006 and 2014, an increase
in the prevalence of overweight (BMI ≥ 25 kg/m2, 52.5%
vs 43%. In that same period, obesity (BMI ≥ 30
kg/m2 increased from 11.9% to 17.9%, predominating among
35-to-64-year-old individuals and women (18.2% vs 17.9%),
but remained stable from 2012 to 2014.
Salt intake
The excessive consumption of sodium, one of the major RF for AH, associates
with CV and renal events.[22,23]In Brazil, data of the Survey on Family Income (POF), collect from 55,970
dwellings, have shown home availability of 4.7g of sodium/person/day
(adjusted for the consumption of 2,000 kcal), exceeding more than twice the
maximum recommended consumption (2 g/day), lower in the urban area of the
Southeastern region, and higher in the rural area of the Northern
region.[24]The impact of the sodium-rich diet estimated in the 2014 VIGITEL data showed
that only 15.5% of the individuals interviewed acknowledged high or
extremely high salt content in their meals.[12]
Alcohol intake
A chronic and high consumption of alcoholic beverages increases BP
consistently. A meta-analysis of 2012, including 16 studies with 33,904 men
and 19,372 women compared the consumption intensity between non-drinkers and
drinkers.[25] For
women, there was a protective effect with doses lower than 10g of
alcohol/day, and risk for AH with a consumption of 30-40g of alcohol/day.
For men, the increased risk for AH became consistent from 31g of alcohol/day
onwards.The 2006-2013 VIGITEL data showed that abusive alcohol consumption - at least
four doses for women, or at least five doses for men, of alcoholic beverages
on the same occasion, within the past 30 days - is stable in the adult
population, around 16.4% (24.2% for men and 9.7% for women). For both sexes,
abusive alcohol consumption was more often among youngsters, and increased
with schooling.[25]
Sedentary lifestyle
A population-based study in the city of Cuiabá, Mato Grosso State, (n
= 1,298 adults ≥ 18 years) has revealed a 75.8% overall prevalence of
sedentary lifestyle (33.6% during leisure time; 19.9% at work; 22.3% during
both). A significant association of AH was observed with age, male sex,
overweight, central adiposity, sedentary lifestyle during leisure time and
work, less than 8 years of schooling, per capita income
< 3 minimum wages.[26]Brazilian National Health Survey (PNS) data indicate that insufficiently
active individuals (adults not practicing at least 150 minutes per week of
physical activity including leisure, work and displacement time) represent
46.0% of the adults, the percentage being significantly higher among women
(51.5%). The frequencies of insufficiently active individuals differed
between age groups, mainly among the elderly (62.7%) and the adults with no
formal education and those with incomplete elementary education
(50.6%).[27]
Socioeconomic factors
Adults with lower schooling (no formal education or incomplete elementary
education) have a higher prevalence of self-reported AH (31.1%). The
proportion decreases among those with complete elementary education (16.7%),
being 18.2% among those with complete higher education.[26] However, the ELSA Brazil
Study, performed with employees of six Brazilian universities and
university-affiliated hospitals with higher schooling, has shown a 35.8% AH
prevalence, higher among men.[11]
Genetics
Brazilian studies assessing the impact of genetic polymorphisms in the
quilombola population could not identify a more
prevalent pattern, showing the strong impact of miscegenation, and hindering
the identification of a genetic pattern for the elevation of BP
levels.[28,29]
Strategies for the implementation of preventive measures
The strategies for preventing the development of AH comprise public policies for
health in combination with action from the medical societies and communication
media. They should be aimed at stimulating early diagnosis, continuous
treatment, control of BP and associated RF, by use of lifestyle changes and/or
regular use of medications.
Authors: Angela B S Santos; Deepak K Gupta; Natalie A Bello; Mauro Gori; Brian Claggett; Flavio D Fuchs; Amil M Shah; Josef Coresh; A Richey Sharrett; Susan Cheng; Scott D Solomon Journal: Am J Hypertens Date: 2015-09-07 Impact factor: 2.689
Authors: Stephen S Lim; Theo Vos; Abraham D Flaxman; Goodarz Danaei; Kenji Shibuya; Heather Adair-Rohani; Markus Amann; H Ross Anderson; Kathryn G Andrews; Martin Aryee; Charles Atkinson; Loraine J Bacchus; Adil N Bahalim; Kalpana Balakrishnan; John Balmes; Suzanne Barker-Collo; Amanda Baxter; Michelle L Bell; Jed D Blore; Fiona Blyth; Carissa Bonner; Guilherme Borges; Rupert Bourne; Michel Boussinesq; Michael Brauer; Peter Brooks; Nigel G Bruce; Bert Brunekreef; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Fiona Bull; Richard T Burnett; Tim E Byers; Bianca Calabria; Jonathan Carapetis; Emily Carnahan; Zoe Chafe; Fiona Charlson; Honglei Chen; Jian Shen Chen; Andrew Tai-Ann Cheng; Jennifer Christine Child; Aaron Cohen; K Ellicott Colson; Benjamin C Cowie; Sarah Darby; Susan Darling; Adrian Davis; Louisa Degenhardt; Frank Dentener; Don C Des Jarlais; Karen Devries; Mukesh Dherani; Eric L Ding; E Ray Dorsey; Tim Driscoll; Karen Edmond; Suad Eltahir Ali; Rebecca E Engell; Patricia J Erwin; Saman Fahimi; Gail Falder; Farshad Farzadfar; Alize Ferrari; Mariel M Finucane; Seth Flaxman; Francis Gerry R Fowkes; Greg Freedman; Michael K Freeman; Emmanuela Gakidou; Santu Ghosh; Edward Giovannucci; Gerhard Gmel; Kathryn Graham; Rebecca Grainger; Bridget Grant; David Gunnell; Hialy R Gutierrez; Wayne Hall; Hans W Hoek; Anthony Hogan; H Dean Hosgood; Damian Hoy; Howard Hu; Bryan J Hubbell; Sally J Hutchings; Sydney E Ibeanusi; Gemma L Jacklyn; Rashmi Jasrasaria; Jost B Jonas; Haidong Kan; John A Kanis; Nicholas Kassebaum; Norito Kawakami; Young-Ho Khang; Shahab Khatibzadeh; Jon-Paul Khoo; Cindy Kok; Francine Laden; Ratilal Lalloo; Qing Lan; Tim Lathlean; Janet L Leasher; James Leigh; Yang Li; John Kent Lin; Steven E Lipshultz; Stephanie London; Rafael Lozano; Yuan Lu; Joelle Mak; Reza Malekzadeh; Leslie Mallinger; Wagner Marcenes; Lyn March; Robin Marks; Randall Martin; Paul McGale; John McGrath; Sumi Mehta; George A Mensah; Tony R Merriman; Renata Micha; Catherine Michaud; Vinod Mishra; Khayriyyah Mohd Hanafiah; Ali A Mokdad; Lidia Morawska; Dariush Mozaffarian; Tasha Murphy; Mohsen Naghavi; Bruce Neal; Paul K Nelson; Joan Miquel Nolla; Rosana Norman; Casey Olives; Saad B Omer; Jessica Orchard; Richard Osborne; Bart Ostro; Andrew Page; Kiran D Pandey; Charles D H Parry; Erin Passmore; Jayadeep Patra; Neil Pearce; Pamela M Pelizzari; Max Petzold; Michael R Phillips; Dan Pope; C Arden Pope; John Powles; Mayuree Rao; Homie Razavi; Eva A Rehfuess; Jürgen T Rehm; Beate Ritz; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Jose A Rodriguez-Portales; Isabelle Romieu; Robin Room; Lisa C Rosenfeld; Ananya Roy; Lesley Rushton; Joshua A Salomon; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; Amir Sapkota; Soraya Seedat; Peilin Shi; Kevin Shield; Rupak Shivakoti; Gitanjali M Singh; David A Sleet; Emma Smith; Kirk R Smith; Nicolas J C Stapelberg; Kyle Steenland; Heidi Stöckl; Lars Jacob Stovner; Kurt Straif; Lahn Straney; George D Thurston; Jimmy H Tran; Rita Van Dingenen; Aaron van Donkelaar; J Lennert Veerman; Lakshmi Vijayakumar; Robert Weintraub; Myrna M Weissman; Richard A White; Harvey Whiteford; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Warwick Williams; Nicholas Wilson; Anthony D Woolf; Paul Yip; Jan M Zielinski; Alan D Lopez; Christopher J L Murray; Majid Ezzati; Mohammad A AlMazroa; Ziad A Memish Journal: Lancet Date: 2012-12-15 Impact factor: 79.321
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190
Authors: L Kimura; C B Angeli; M T B M Auricchio; G R Fernandes; A C Pereira; J P Vicente; T V Pereira; R C Mingroni-Netto Journal: Int J Hypertens Date: 2012-09-26 Impact factor: 2.420
Authors: Amanda P Silva; Erika V Araujo; Igor P Machado; Livia F Alves; Marcos F DA Silva Mello; Pedro Henrique DE A Silva; Isabella R Dias; Viviane Soares Journal: Int J Exerc Sci Date: 2021-04-01
Authors: Juan Carlos Yugar-Toledo; Heitor Moreno Júnior; Miguel Gus; Guido Bernardo Aranha Rosito; Luiz César Nazário Scala; Elizabeth Silaid Muxfeldt; Alexandre Alessi; Andrea Araújo Brandão; Osni Moreira Filho; Audes Diógenes de Magalhães Feitosa; Oswaldo Passarelli Júnior; Dilma do Socorro Moraes de Souza; Celso Amodeo; Weimar Kunz Sebba Barroso; Marco Antônio Mota Gomes; Annelise Machado Gomes de Paiva; Eduardo Costa Duarte Barbosa; Roberto Dischinger Miranda; José Fernando Vilela-Martin; Wilson Nadruz Júnior; Cibele Isaac Saad Rodrigues; Luciano Ferreira Drager; Luiz Aparecido Bortolotto; Fernanda Marciano Consolim-Colombo; Márcio Gonçalves de Sousa; Flávio Antonio de Oliveira Borelli; Sérgio Emanuel Kaiser; Gil Fernando Salles; Maria de Fátima de Azevedo; Lucélia Batista Neves Cunha Magalhães; Rui Manoel Dos Santos Póvoa; Marcus Vinícius Bolívar Malachias; Armando da Rocha Nogueira; Paulo César Brandão Veiga Jardim; Thiago de Souza Veiga Jardim Journal: Arq Bras Cardiol Date: 2020 May-Jun Impact factor: 2.000
Authors: Anderson de Oliveira Vieira; Gabriel Antônio Nogueira Nascentes; Ana Carolina de Morais Oliveira; Dalmo Correia; Marlene Cabrine-Santos Journal: Parasitol Res Date: 2020-11-11 Impact factor: 2.289
Authors: Francisco Flavio Costa Filho; Ari Timerman; Jose Francisco Kerr Saraiva; Carlos Costa Magalhaes; Ibraim Masciarelli F Pinto; Gustavo B F Oliveira; Antonio Cordeiro Mattos; Alvaro Avezum Journal: J Clin Hypertens (Greenwich) Date: 2017-11-23 Impact factor: 3.738